Dr. Yuling Shi is a professor of dermatology, the Vice President of Shanghai Skin Disease Hospital at the Tongji University School of Medicine, and the founder and director of the Institute of Psoriasis at Tongji University School of Medicine, the first psoriasis institute in China. Dr. Shi has previously pursued postdoctoral training as a Fellow at Henry Ford Hospital Immunology and Dermatology Research program. She has led several research initiatives and programs supported by the National Natural Science Foundation of China and other national organizations. Her work includes investigating the skin inflammatory microenvironment in psoriasis. Additionally, Dr. Shi explored the appropriate use of systematic therapies for psoriasis in Asian populations. Over the past decade, she has published over 90 peer-reviewed articles in journals such as BMJ, Immunity, Nat Immunol, Sci Immunol, JAAD, JID, JCI insight, etc., with the majority focusing on psoriasis, skin autoimmunity, and inflammatory skin disease. Dr. Shi has made significant contributions to advancing the understanding of psoriasis pathogenesis and treatment strategies.
Areas of Interest
Studying and optimizing the treatment strategies for psoriasis, such as investigating the best incremental dose regimen of narrow-band ultraviolet B for treating Chinese psoriasis patients; cellular and molecular mechanism of the development and relapse of psoriasis